JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
RH
RH
$2.2B
| $9.09M | ﹤0.01% |
34,033
-1,190
| -3% | -$310K |
2013 Q2
38 quarters
|
|
|
ALE
2252
DELISTED
Allete
ALE
| $9.08M | ﹤0.01% |
140,748
-6,913
| -5% | -$410K |
2015 Q4
28 quarters
|
|
2253
Liberty Energy
LBRT
$3.27B
| $9.07M | ﹤0.01% |
566,490
+426,765
| +305% | +$6.79M |
2018 Q1
19 quarters
|
|
2254
United Natural Foods
UNFI
$2.72B
| $9.07M | ﹤0.01% |
234,325
+4,220
| +2% | +$175K |
2015 Q4
28 quarters
|
|
2255
Tandem Diabetes Care
TNDM
$1.15B
| $9.07M | ﹤0.01% |
201,698
+40,695
| +25% | +$1.84M |
2018 Q1
19 quarters
|
|
2256
Avis
CAR
$3.87B
| $9.06M | ﹤0.01% |
55,257
-112,799
| -67% | -$22.6M |
2013 Q2
38 quarters
|
|
|
ROIC
2257
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $9.05M | ﹤0.01% |
602,430
-943,816
| -61% | -$13.8M |
2013 Q2
38 quarters
|
|
2258
O-I Glass
OI
$865M
| $9.05M | ﹤0.01% |
546,273
+137,501
| +34% | +$2.21M |
2013 Q2
38 quarters
|
|
2259
PUT
Philip Morris
PM
$297B
| $9M | ﹤0.01% |
88,900
+15,900
| +22% | +$1.5M |
2021 Q4
4 quarters
|
|
2260
DXC Technology
DXC
$1.88B
| $8.97M | ﹤0.01% |
338,477
-416,964
| -55% | -$11.6M |
2017 Q2
22 quarters
|
|
2261
Dolby
DLB
$5.5B
| $8.97M | ﹤0.01% |
127,134
-37,396
| -23% | -$2.58M |
2015 Q4
28 quarters
|
|
2262
CALL
UnitedHealth
UNH
$337B
| $8.96M | ﹤0.01% |
16,900
+12,200
| +260% | +$6.46M |
2021 Q2
6 quarters
|
|
|
AZPN
2263
DELISTED
Aspen Technology Inc
AZPN
| $8.95M | ﹤0.01% |
43,590
-10,988
| -20% | -$2.55M |
2022 Q2
2 quarters
|
|
2264
Twilio
TWLO
$44.6B
| $8.95M | ﹤0.01% |
182,804
-519,889
| -74% | -$29.6M |
2016 Q2
26 quarters
|
|
|
BLUE
2265
DELISTED
bluebird bio
BLUE
| $8.95M | ﹤0.01% |
64,652
+3,308
| +5% | +$466K |
2014 Q3
33 quarters
|
|
2266
iShares ESG Advanced MSCI EAFE ETF
DMXF
$1.03B
| $8.95M | ﹤0.01% |
164,840
+164,825
| +1,098,833% | +$8.53M |
2022 Q3
1 quarter
|
|
2267
Vanguard Materials ETF
VAW
$2.88B
| $8.94M | ﹤0.01% |
52,521
+10,174
| +24% | +$1.71M |
2015 Q4
28 quarters
|
|
2268
InMode
INMD
$807M
| $8.92M | ﹤0.01% |
249,843
+176,190
| +239% | +$6.13M |
2019 Q4
12 quarters
|
|
2269
ATI
ATI
$25.8B
| $8.86M | ﹤0.01% |
296,615
-65,822
| -18% | -$1.93M |
2016 Q4
24 quarters
|
|
|
MZTI
2270
The Marzetti Company
MZTI
$2.73B
| $8.85M | ﹤0.01% |
44,851
+831
| +2% | +$158K |
2014 Q3
33 quarters
|
|
2271
iShares Intermediate Government/Credit Bond ETF
GVI
$3.73B
| $8.84M | ﹤0.01% |
86,309
+3,003
| +4% | +$307K |
2013 Q2
38 quarters
|
|
2272
CVR Energy
CVI
$5.64B
| $8.84M | ﹤0.01% |
282,118
+46,088
| +20% | +$1.64M |
2013 Q2
38 quarters
|
|
|
RADI
2273
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $8.82M | ﹤0.01% |
746,035
+63,207
| +9% | +$655K |
2021 Q2
6 quarters
|
|
|
RDUS
2274
DELISTED
Radius Recycling
RDUS
| $8.81M | ﹤0.01% |
287,361
-12,819
| -4% | -$396K |
2013 Q2
38 quarters
|
|
2275
CALL
BioMarin Pharmaceuticals
BMRN
$10.9B
| $8.8M | ﹤0.01% |
+85,000
| New | +$7.98M |
2022 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.